X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs BIOCON LTD - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. BIOCON LTD WOCKHARDT LTD./
BIOCON LTD
 
P/E (TTM) x 17.1 36.6 46.8% View Chart
P/BV x 1.7 4.9 35.9% View Chart
Dividend Yield % 0.0 1.5 -  

Financials

 WOCKHARDT LTD.   BIOCON LTD
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-16
BIOCON LTD
Mar-16
WOCKHARDT LTD./
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs2,000496 403.5%   
Low Rs706397 178.0%   
Sales per share (Unadj.) Rs403.7174.3 231.7%  
Earnings per share (Unadj.) Rs29.544.8 65.8%  
Cash flow per share (Unadj.) Rs42.456.9 74.4%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs323.4202.8 159.5%  
Shares outstanding (eoy) m110.51200.00 55.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.42.6 130.9%   
Avg P/E ratio x45.910.0 461.1%  
P/CF ratio (eoy) x31.97.8 407.4%  
Price / Book Value ratio x4.22.2 190.2%  
Dividend payout %011.2 0.0%   
Avg Mkt Cap Rs m149,50989,220 167.6%   
No. of employees `0007.44.4 167.1%   
Total wages/salary Rs m9,4436,363 148.4%   
Avg. sales/employee Rs Th6,048.67,894.5 76.6%   
Avg. wages/employee Rs Th1,280.21,441.2 88.8%   
Avg. net profit/employee Rs Th441.52,029.7 21.8%   
INCOME DATA
Net Sales Rs m44,61434,854 128.0%  
Other income Rs m970845 114.7%   
Total revenues Rs m45,58435,699 127.7%   
Gross profit Rs m5,0388,200 61.4%  
Depreciation Rs m1,4262,423 58.8%   
Interest Rs m1,012102 992.3%   
Profit before tax Rs m3,5706,520 54.8%   
Minority Interest Rs m-65-744 8.8%   
Prior Period Items Rs m60-   
Extraordinary Inc (Exp) Rs m05,754 0.0%   
Tax Rs m2552,569 9.9%   
Profit after tax Rs m3,2578,961 36.3%  
Gross profit margin %11.323.5 48.0%  
Effective tax rate %7.139.4 18.1%   
Net profit margin %7.325.7 28.4%  
BALANCE SHEET DATA
Current assets Rs m39,90639,932 99.9%   
Current liabilities Rs m18,42316,276 113.2%   
Net working cap to sales %48.267.9 70.9%  
Current ratio x2.22.5 88.3%  
Inventory Days Days9054 168.4%  
Debtors Days Days9886 114.0%  
Net fixed assets Rs m35,83239,101 91.6%   
Share capital Rs m5531,000 55.3%   
"Free" reserves Rs m30,37038,591 78.7%   
Net worth Rs m35,73940,556 88.1%   
Long term debt Rs m16,54220,724 79.8%   
Total assets Rs m79,52284,816 93.8%  
Interest coverage x4.564.9 7.0%   
Debt to equity ratio x0.50.5 90.6%  
Sales to assets ratio x0.60.4 136.5%   
Return on assets %5.410.7 50.2%  
Return on equity %9.122.1 41.2%  
Return on capital %8.719.0 45.6%  
Exports to sales %11.630.7 37.7%   
Imports to sales %4.520.4 21.9%   
Exports (fob) Rs m5,17710,717 48.3%   
Imports (cif) Rs m1,9907,105 28.0%   
Fx inflow Rs m7,58911,789 64.4%   
Fx outflow Rs m2,8788,393 34.3%   
Net fx Rs m4,7113,396 138.7%   
CASH FLOW
From Operations Rs m7165,264 13.6%  
From Investments Rs m-8,182-9,540 85.8%  
From Financial Activity Rs m2,54310,867 23.4%  
Net Cashflow Rs m-4,9236,591 -74.7%  

Share Holding

Indian Promoters % 74.5 40.4 184.4%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 2.3 8.4 27.4%  
FIIs % 7.7 10.7 72.0%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 19.9 77.4%  
Shareholders   67,757 109,995 61.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   WYETH LTD  PIRAMAL ENTERPRISES  JUBILANT LIFE SCIENCES  SUN PHARMA  PFIZER  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Aug 17, 2017 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 5-YR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS